Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 9 results for "gilead sciences"

Gilead wins reversal of $2.54 billion hepatitis C drug patent ...

(Reuters) - A federal judge in Delaware has overturned a jury's verdict requiring Gilead Sciences Inc to pay a record $2.54 billion because its hepatitis C drugs Sovaldi and Harvoni infringed a patent held by rival Merck & Co Inc. Reuters, 4 days ago

U.S. FDA approves Gilead triple HIV drug, rival files lawsuit

(Reuters) - The U.S. Food and Drug Administration on Wednesday approved Biktarvy, Gilead Sciences Inc's once-daily, triple-combination tablet for treatment of HIV infection, paving the way for the biotech company to capture more of the multibillion-dollar HIV ...
 Reuters1 week ago
Business Standard

Pharma cos leaning on $850,000 therapy to justify super-expensive drugs

An influx of very expensive drugs that offer a one-time cure, such as a hepatitis C therapy from Gilead Sciences, has already stretched state and federal budgets Reuters | San Francisco Last Updated at January 13, 2018 10:15 IST Global drugmakers are looking ...
 Business Standard1 month ago

Florida man gets prison for trading on tip about Gilead deal

(Reuters) - A Florida man was sentenced on Wednesday to one year in prison for engaging in insider trading based on a tip he received from an ex-Morgan Stanley broker about Gilead Sciences Inc's planned $11.2 billion purchase of Pharmasset Inc in 2011, ...
 Business Standard1 month ago

Gilead's new drug keeps 56 percent of lymphoma trial patients alive

(Reuters) - More than half of trial patients with an advanced, aggressive form of blood cancer lived for at least a year after one-time treatment with Yescarta, a novel therapy sold by Gilead Sciences Inc, according to study results presented on Sunday.
 Reuters2 months ago

Sensex Trades 322 Points Up; Auto & IT Stocks Rise

Posted by Equitymaster After opening the day on a strong note, the Indian share markets have continued the momentum and are presently trading higher. Sectoral indices are trading in mixed, with stocks in the automobile sector & information technology sector ...
 Equitymaster.com3 weeks ago

Cipla receives final approval for Generic Viread tablets

Cipla has received final approval for its abbreviated new drug application (ANDA) for Tenofovir Disoproxil Fumarate tablets, 300mg, from the United States Food and Drug Administration (USFDA) to market a generic version of Gilead Sciences#39; Viread Tablets, ...
 Money Control3 weeks ago

Natco launches Hepatitis B drug

Natco Pharma today said it has launched a generic version of Tenofovir Alafenamide, a drug used to treat chronic Hepatitis B in the country.The company is one of the first entities to launch the generic version of the drug under its brand Tafnat, Natco Pharma ...
 Business Standard2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less